Also trades as: SABS (NASDAQ) · $vol 2M
SABSW NASDAQ
SAB Biotherapeutics, Inc.
1W: -89.0%
1M: -92.1%
3M: -90.1%
YTD: -96.5%
1Y: -95.8%
3Y: -97.8%
$0.00
-0.00 (-74.42%)
Credit Risk of going bust: lower than 69% of companies Debt: 1.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99%), SAB Biotherapeutics, Inc. would be worth roughly what it owes.
Total debt $5.1M against a stock market value of $279.3M.
Distance to default 7.40 (Merton model): prices to 2026-10-21, balance sheet 2026-06-30, debt counted $2.9M (short-term plus half of long-term), stock volatility 60.6%; Altman Z'' 9.84. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down 99%), SAB Biotherapeutics, Inc. would be worth roughly what it owes.
Total debt $5.1M against a stock market value of $279.3M.
Distance to default 7.40 (Merton model): prices to 2026-10-21, balance sheet 2026-06-30, debt counted $2.9M (short-term plus half of long-term), stock volatility 60.6%; Altman Z'' 9.84. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Oct Typical
⛈️
Stormy
-47.9% YTD avg
Midterm Year
⛈️
Stormy
-97.3% YTD avg
2026 Now
⛈️
Stormy
Below typical
20yr Avg YTD
-47.9%
Day 185 of 252
Midterm Year YTD
-97.3%
Presidential cycle avg
2026 YTD
-96.5%
Below 20yr avg
Typical Vol
298%
Annualized
Monthly Weather Forecast
Jan
20yr
⛈️
+16.1%
Midterm
⛈️
-40.6%
40% win
302% vol
Feb
20yr
⛈️
+11.8%
Midterm
⛈️
-81.6%
20% win
328% vol
Mar
20yr
⛈️
-26.6%
Midterm
⛈️
-74.2%
60% win
210% vol
Apr
20yr
⛈️
+19.5%
Midterm
⛈️
-86.2%
20% win
468% vol
May
20yr
💨
+29.6%
Midterm
⛈️
-91.2%
60% win
479% vol
Jun
20yr
💨
+23.3%
Midterm
⛈️
-92.0%
60% win
858% vol
Jul
20yr
💨
+41.0%
Midterm
⛈️
-90.9%
40% win
350% vol
Aug
20yr
⛈️
+38.5%
Midterm
⛈️
-95.7%
20% win
321% vol
Sep
20yr
⛈️
-58.0%
Midterm
⛈️
-96.7%
0% win
238% vol
Oct
20yr
💨
+9.7%
Midterm
⛈️
-8.1%
67% win
298% vol
Now:
-92.1%
Nov
20yr
💨
+19.4%
Midterm
💨
+3.8%
60% win
259% vol
Dec
20yr
⛈️
-16.0%
Midterm
⛈️
-21.3%
40% win
378% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: -96.5%